Schonfeld Strategic Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-589,332
| Closed | -$375K | – | 1996 |
|
|
2025
Q1 | $375K | Sell |
589,332
-791,468
| -57% | -$503K | ﹤0.01% | 1581 |
|
|
2024
Q4 | $1.42M | Buy |
1,380,800
+169,000
| +14% | +$174K | 0.01% | 921 |
|
|
2024
Q3 | $1.43M | Sell |
1,211,800
-163,490
| -12% | -$193K | 0.01% | 905 |
|
|
2024
Q2 | $1.68M | Buy |
1,375,290
+100,783
| +8% | +$123K | 0.01% | 868 |
|
|
2024
Q1 | $2.78M | Buy |
+1,274,507
| New | +$2.78M | 0.02% | 727 |
|
|
2022
Q1 | – | Sell |
-19,800
| Closed | -$85K | – | 2437 |
|
|
2021
Q4 | $85K | Buy |
+19,800
| New | +$85K | ﹤0.01% | 1835 |
|